MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
Phase 2
Not yet recruiting
- Conditions
- Refractory Multiple MyelomaMultiple MyelomaRelapsed Cancer
- Interventions
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05922501
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Ultrahypofractionation and Normal Tissue Toxicity
Not Applicable
Recruiting
- Conditions
- Breast CancerBreast Cancer FemaleBreast Cancer Stage IIBreast Cancer Stage IIIMyocardial Fibrosis
- Interventions
- Radiation: Accelerated Proton Beam Radiation Therapy (PBT)Radiation: Accelerated Photon Radiation Therapy (XRT)
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05912231
- Locations
- 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
Not Applicable
Recruiting
- Conditions
- Self EfficacyRectal Cancer
- Interventions
- Other: Enhanced usual careBehavioral: PATHWAYS
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT05914766
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
Not Applicable
Not yet recruiting
- Conditions
- Mild Cognitive ImpairmentAlzheimer Disease
- Interventions
- Device: tACS device
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT05904132
- Locations
- 🇺🇸
Massachusetts General Hospital, Charlestown, Massachusetts, United States
Delayed Tolerance Through Mixed Chimerism
Phase 1
Recruiting
- Conditions
- Kidney FailureKidney Transplant; ComplicationsChimera
- Interventions
- Other: Bone Marrow TransplantProcedure: Peripheral Blood Stem Cell Collection
- First Posted Date
- 2023-06-12
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05900401
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Lung Cancer Screening in High-risk Black Women
Not Applicable
Recruiting
- Conditions
- Lung CarcinomaLung Cancer
- Interventions
- Procedure: Low-dose Computed Tomography
- First Posted Date
- 2023-06-12
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 900
- Registration Number
- NCT05898594
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
Early Phase 1
Recruiting
- Conditions
- Pulmonary EmbolismVenous ThromboembolismMetabolomicsOxygen Inhalation Therapy
- Interventions
- Device: Non-rebreather mask
- First Posted Date
- 2023-06-07
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT05891886
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Testing the Integrated mHealth App Intervention "SiS-H"
Not Applicable
Recruiting
- Conditions
- Smoking Cessation
- Interventions
- Behavioral: Smiling instead of Smoking - HIVBehavioral: QuitGuide
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 64
- Registration Number
- NCT05886621
- Locations
- 🇺🇸
Behavioral Medicine Program (BMED), Boston, Massachusetts, United States
Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
Recruiting
- Conditions
- Subjective Cognitive ConcernsHealthy AgingMild Behavioral ImpairmentMild Cognitive Impairment
- Interventions
- Device: AROMHA Brain Health Test
- First Posted Date
- 2023-05-31
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 250
- Registration Number
- NCT05881239
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
Not Applicable
Recruiting
- Conditions
- Electronic Cigarette Use
- Interventions
- Device: Standardized research e-cigarette (SREC)
- First Posted Date
- 2023-05-31
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05881304
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath